Physician profile
Luke Miller
NPI 1457618050
$2,402.09
in general payments reported to CMS, 2019-2025
12 companies · $127 in 2025
The $127 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $117 · 2021: $2,000 · 2023: $26.30 · 2024: $131 · 2025: $127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $285.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $285.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $2,000.00 | 2021 | |
| Allergan, INC. | $116.94 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $100.89 | 2024 | Airsupra |
| Lilly USA, LLC | $32.39 | 2024-2025 | Zepbound, Mounjaro |
| Teleflex LLC | $29.28 | 2025 | Arrow |
| Astellas Pharma US INC | $23.64 | 2025 | Veozah |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $23.05 | 2025 | Caplyta |
| Sumitomo Pharma America, INC. | $17.73 | 2025 | Gemtesa |
| Vanda Pharmaceuticals INC. | $17.32 | 2025 | Fanapt, Hetlioz |
| Exact Sciences Corporation | $14.55 | 2024 | Cologuard Collection Kit |
| Abbvie INC. | $13.55 | 2023 | |
| Corium, LLC | $12.75 | 2023 | Azstarys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luke Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.